Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives

Diabetologia

Volumn 51, Issue 3, 2008, Pages 488-492

  Achenbach, P ^a   Bonifacio, E ^a   Williams, A J K ^b   Ziegler, A G ^a   Gale, E A M ^b   Bingley, P J ^b  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

First phase insulin response; IA 2 ; Islet autoantibodies; Prediction; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; IA ANTIBODY; BIOLOGICAL MARKER; ICA512 AUTOANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE; GROUPS BY AGE; HUMAN; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RELATIVE; UNIVARIATE ANALYSIS; ANALYSIS OF VARIANCE; BLOOD; FAMILY; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; RADIOASSAY; RISK ASSESSMENT;

ANALYSIS OF VARIANCE; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; FAMILY; GLUCOSE TOLERANCE TEST; HUMANS; RADIOLIGAND ASSAY; RISK ASSESSMENT;

EID: 39049158164     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0912-9     Document Type: Article

References (10)

1. Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392
2. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EAM (1997) Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710
3. Decochez K, De Leeuw IH, Keymeulen B et al (2002) IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 45:1658-1666
4. Krischer JP, Cuthbertson DD, Yu L et al (2003) Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 88:103-108
5. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E (2004) Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 114:589-597
6. Mayr A, Schlosser M, Grober N et al (2007) GAD Autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 56:1527-1533
7. Gale EAM, Bingley PJ, Emmett CL, Collier T (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931
8. Bingley PJ, Gale EAM (2006) Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 49:881-890
9. Bonifacio E, Lampasona V, Bingley PJ (1998) IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. J Immunol 161:2648-2654
10. Diabetes Prevention Trial-Type 1 Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685-1691